University of Kentucky Medical Center
Lexington, Kentucky, United States
Hospital in Lexington, Kentucky
1000 S Limestone, Lexington, KY 40536
About University of Kentucky Medical Center
UK HealthCare is the health care system that is based on the campus of the University of Kentucky in Lexington, Kentucky. It consists of the university's hospitals, clinics, outreach locations, and patient care services along with UKs health profession colleges.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Kentucky
10
Celgene
7
Baxalta now part of Shire
4
BioMarin Pharmaceutical
4
Bristol-Myers Squibb
4
Millennium Pharmaceuticals, Inc.
4
NSABP Foundation Inc
4
United Therapeutics
4
Biogen
3
Boehringer Ingelheim
3
C. R. Bard
3
Clinical Trials at University of Kentucky Medical Center
During the past decade, University of Kentucky Medical Center conducted 76 clinical trials. In the 10-year time frame, 76 clinical trials started and 58 clinical trials were completed, i.e. on
average, 76.3% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 25 clinical trials were completed. i.e. 166.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis
Completed
450
A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs
Completed
40
A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine
Suspended
186
Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs
1999-09-01
Completed
Safety and Effectiveness of a Combination Anti-HIV Drug Treatment
1999-07-01
2000-10-01
Completed
150
Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)
2001-02-01
2003-09-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Kentucky Medical Center" #1 sponsor was "University of Kentucky" with 10 trials, followed by "Celgene" with 7 trials
sponsored, "Baxalta now part of Shire" with 4 trials sponsored, "BioMarin Pharmaceutical" with 4 trials sponsored and "Bristol-Myers Squibb"
with 4 trials sponsored. Other sponsors include 145 different institutions and
companies that sponsored additional 116 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kentucky Medical Center"
#1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 10 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 9 trials as a collaborator, "Medical University of South Carolina" with 5 trials as a collaborator, "University of Kentucky" with 4 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator. Other collaborators include 77 different institutions and companies that were
collaborators in the rest 75 trials.
Clinical Trials Conditions at University of Kentucky Medical Center
According to Clinical.Site data, the most researched conditions in "University of Kentucky Medical Center" are
"HIV Infections" (10 trials), "Crohn's Disease" (8 trials), "Ulcerative Colitis" (7 trials), "Breast Cancer" (6 trials) and "Crohn Disease" (5 trials). Many other conditions were trialed in "University of Kentucky Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at University of Kentucky Medical Center
Most popular intervention types in "University of Kentucky Medical Center" are "Drug" (117 trials), "Device" (22 trials), "Other" (21 trials), "Biological" (15 trials) and "Procedure" (11 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (37 trials), "placebo" (5 trials), "Lamivudine" (3 trials), "Methylphenidate" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.
Clinical Trials Genders at University of Kentucky Medical Center
The vast majority of trials in "University of Kentucky Medical Center" are
170 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at University of Kentucky Medical Center
Currently, there are 29 active trials in "University of Kentucky Medical Center".
1 are not yet recruiting,
22 are recruiting,
5 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 103 completed trials in University of Kentucky Medical Center,
undefined suspended trials,
and 29 terminated clinical trials to date.
Out of the total trials that were conducted in University of Kentucky Medical Center, 20 "Phase 1"
clinical trials were conducted, 36 "Phase 2" clinical
trials and 62 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 11 trials, and there were
also 28 trials that are defined as “Not Applicable".